Continuous Glucose Monitoring Systems Market Research Report Information by Product (Sensors, And Transmitter and Receivers), By Application (Type 2, Type 1, Non-diabetic Patients), By End User (Hospitals & Clinics, Homecare Settings, And Others), by Regi

Continuous Glucose Monitoring Systems Market Research Report Information by Product (Sensors, And Transmitter and Receivers), By Application (Type 2, Type 1, Non-diabetic Patients), By End User (Hospitals & Clinics, Homecare Settings, And Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032

In 2023, the market for continuous glucose monitoring systems was estimated to be worth USD 8.8 billion. The market for continuous glucose monitoring systems is expected to expand at a compound annual growth rate (CAGR) of 12.34% between 2024 and 2032, from USD 10.0 billion in 2024 to USD 25.8 billion.

One significant factor supporting the global market expansion for continuous glucose monitoring systems is the rising incidence of diabetes. Diabetes has become an epidemic, with a startling increase in the number of people affected worldwide. The International Diabetes Federation (IDF) estimates that 537 million people globally had diabetes in 2021, and by 2030, that figure is projected to rise to 643 million. Similarly, 38.4 million Americans, or 11.6% of the population, had diabetes in 2021, according to the American Diabetes Association. An estimated 2.0 million Americans suffer from type 1 diabetes, of which 304,000 are children and teenagers. The aging population, bad eating habits, and sedentary lifestyles are some of the causes contributing to the rising prevalence of diabetes. There is an increasing need for efficient diabetes care strategies due to the growing number of people with diabetes.

Insights on Market Segments
Based on product, the market segmentation for continuous glucose monitoring systems comprises sensors, transmitters, and receivers.
Patients without diabetes, those with type 1 diabetes, and those with type 2 diabetes are all included in the market segmentation based on application.
Hospitals and clinics, homecare settings, and others are included in the market segmentation based on end users.

Regional Perspectives
The market is divided into four regions by the study: North America, Europe, Asia-Pacific, and the Rest of the World. North America In 2023, the market for continuous glucose monitoring systems held the biggest market share. This is a result of the strong technical foundation, and the market is anticipated to be driven by an established regulatory framework.

The second-largest market share for continuous glucose monitoring systems is held by the European region, owing to the rising incidence of diabetes and the progress made in CGM technology. Furthermore, the market for continuous glucose monitoring systems in France was found to have the biggest market share, and the market for these systems in the rest of Europe is anticipated to develop at the quickest rate in the continent.

From 2023 to 2032, the Asia-Pacific Continuous Glucose Monitoring Systems market is anticipated to expand at a substantial percentage. This is because diabetes is becoming more common in the area and more people are becoming aware of how to control their diabetes. Furthermore, the market for continuous glucose monitoring systems in China is anticipated to have the most share, followed by India. The Asia-Pacific continuous glucose monitoring systems market is anticipated to develop at the quickest rate.

The Middle East & Africa and Latin America are included under the heading ""Remainder of the World."" The market for continuous glucose monitoring systems is expected to expand in the regions as a result of increased diabetes prevalence and growing consumer awareness of sophisticated glucose monitoring devices.

Principal Players

Dexcom, Inc. (US), Menarini Diagnostics SRL (Italy), Sensonics (US), Medtrum Technologies Inc. (China), Nemaura Medical Inc. (US), Ultrahuman Healthcare Pvt Ltd (India), Medtronic (Ireland), One Drop (US), Abbott Laboratories, Inc. (US), and Sinocare (China) are some of the prominent companies in the continuous glucose monitoring systems market.